1. Home
  2. APLS vs EQX Comparison

APLS vs EQX Comparison

Compare APLS & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • EQX
  • Stock Information
  • Founded
  • APLS 2009
  • EQX 2007
  • Country
  • APLS United States
  • EQX Canada
  • Employees
  • APLS N/A
  • EQX N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • EQX Precious Metals
  • Sector
  • APLS Health Care
  • EQX Basic Materials
  • Exchange
  • APLS Nasdaq
  • EQX Nasdaq
  • Market Cap
  • APLS 3.3B
  • EQX 3.1B
  • IPO Year
  • APLS 2017
  • EQX N/A
  • Fundamental
  • Price
  • APLS $18.20
  • EQX $7.01
  • Analyst Decision
  • APLS Buy
  • EQX
  • Analyst Count
  • APLS 18
  • EQX 0
  • Target Price
  • APLS $45.59
  • EQX N/A
  • AVG Volume (30 Days)
  • APLS 2.8M
  • EQX 14.1M
  • Earning Date
  • APLS 05-06-2025
  • EQX 05-07-2025
  • Dividend Yield
  • APLS N/A
  • EQX N/A
  • EPS Growth
  • APLS N/A
  • EQX 738.78
  • EPS
  • APLS N/A
  • EQX 0.75
  • Revenue
  • APLS $781,367,000.00
  • EQX $1,514,120,000.00
  • Revenue This Year
  • APLS $12.71
  • EQX $51.11
  • Revenue Next Year
  • APLS $20.93
  • EQX $16.04
  • P/E Ratio
  • APLS N/A
  • EQX $9.42
  • Revenue Growth
  • APLS 97.02
  • EQX 39.14
  • 52 Week Low
  • APLS $17.49
  • EQX $4.48
  • 52 Week High
  • APLS $53.06
  • EQX $7.24
  • Technical
  • Relative Strength Index (RSI)
  • APLS 28.14
  • EQX 56.41
  • Support Level
  • APLS $18.00
  • EQX $6.70
  • Resistance Level
  • APLS $19.71
  • EQX $7.37
  • Average True Range (ATR)
  • APLS 1.63
  • EQX 0.37
  • MACD
  • APLS -0.16
  • EQX 0.08
  • Stochastic Oscillator
  • APLS 10.98
  • EQX 79.78

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About EQX Equinox Gold Corp.

Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.

Share on Social Networks: